TSX:HLS (Canada)  
HLS Therapeutics Inc logo

HLS Therapeutics Inc

C$ 9.03 (+0.33%) Sep 29
On watch
P/E:
At Loss
P/B:
1.59
Market Cap:
C$ 292.70M ($ 213.51M)
Enterprise V:
C$ 389.43M ($ 284.06M)
Volume:
53.75K
Avg Vol (2M):
17.68K
Also Trade In:
Volume:
53.75K
Market Cap C$:
292.70M
Market Cap $:
213.51M
PE Ratio:
At Loss
Avg Vol (2-Month):
17.68K
Enterprise Value C$:
389.43M
Enterprise Value $:
284.06M
PB Ratio:
1.59
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.

Financials

TSX:HLS's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 77.481
EPS (TTM) (C$) -0.74
Beta 1.29
Volatility % 29.36
14-Day RSI 23.93
14-Day ATR (C$) 0.412476
20-Day SMA (C$) 10.0225
12-1 Month Momentum % -34.67
52-Week Range (C$) 8.55 - 20.52
Shares Outstanding (Mil) 32.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

HLS Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

HLS Therapeutics Inc Analysis

Share your research